{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:54:12Z","timestamp":1787014452599,"version":"build-2736575974"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T00:00:00Z","timestamp":1279065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,16]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Common variable immunodeficiency disorders (CVIDs) are a heterogeneous group of diseases characterized by hypogammaglobulinaemia and consequent susceptibility to infection. CVID patients commonly develop a variety of additional manifestations for which the causative factors are not fully understood. Two such manifestations are granulomatous disease and enteropathy. Because the ability to predict complications would aid clinical management, we continue to search for possible disease modifier genes. NOD2 acts a microbial sensor and is involved in proinflammatory signalling. Particular mutations of the NOD2 gene are associated with Crohn's disease including gly908arg, leu1007finsc and arg702trp polymorphisms. We hypothesized that NOD2 polymorphisms may be a disease modifier gene towards an enteropathic or granulomatous phenotype within CVIDs. Sequence-specific primers returned genotypes for 285 CVID patients from centres across the United Kingdom and Europe. We present the frequencies of the different phenotypes of patients within our international cohort. Arg702trp polymorphisms were significantly less frequent than wild-type (WT) (P = 0\u00b7038) among international CVID patients with splenomegaly. Gly908arg polymorphisms were more prevalent than WT in UK patients with autoimmune disorders (P = 0\u00b7049) or enteropathy (P = 0\u00b7049). NOD2 polymorphisms were not more prevalent than WT in CVID patients with clinical phenotypes of granulomata. UK allele frequencies of 0\u00b7014, 0\u00b7056 and 0\u00b7026 were found for gly908arg, arg702trp and leu1007finsc NOD2 polymorphisms, respectively. These do not differ significantly from UK immunocompetent controls confirming, as expected, that in addition these NOD2 polymorphisms do not confer susceptibility to CVIDs per se.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04216.x","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T10:14:13Z","timestamp":1279102453000},"page":"536-541","source":"Crossref","is-referenced-by-count":16,"title":["<i>NOD2<\/i>\n                    polymorphisms in clinical phenotypes of common variable immunodeficiency disorders"],"prefix":"10.1093","volume":"161","author":[{"given":"K","family":"Packwood","sequence":"first","affiliation":[{"name":"Department of Immunology, Oxford Radcliffe Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Drewe","sequence":"additional","affiliation":[{"name":"Department of Immunology, Queens Medical Centre, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Staples","sequence":"additional","affiliation":[{"name":"Department of Immunology, Queens Medical Centre, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Royal Free Hospital, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Witte","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Medical School Hannover, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Litzman","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Allergology, Masaryk University, St Anne University Hospital, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Egner","sequence":"additional","affiliation":[{"name":"Department of Immunology, Northern General Hospital, Sheffield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sargur","sequence":"additional","affiliation":[{"name":"Department of Immunology, Northern General Hospital, Sheffield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Sewell","sequence":"additional","affiliation":[{"name":"Department of Immunology, Path links, Scunthorpe, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lopez-Granados","sequence":"additional","affiliation":[{"name":"Department of Immunology, Oxford Radcliffe Hospitals"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S L","family":"Seneviratne","sequence":"additional","affiliation":[{"name":"Department of Immunology, Oxford Radcliffe Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Powell","sequence":"additional","affiliation":[{"name":"Department of Immunology, Queens Medical Centre, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B L","family":"Ferry","sequence":"additional","affiliation":[{"name":"Department of Immunology, Oxford Radcliffe Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H M","family":"Chapel","sequence":"additional","affiliation":[{"name":"Department of Immunology, Oxford Radcliffe Hospitals"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,14]]},"reference":[{"key":"2021122708485993200_b1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122708485993200_b2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2222.2001.01117.x","article-title":"Current perspectives on common variable immunodeficiency (CVID)","volume":"31","author":"Spickett","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"2021122708485993200_b3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","article-title":"Common variable immunodeficiency: a review","volume":"3","author":"Di Renzo","year":"2004","journal-title":"Clin Exp Med"},{"key":"2021122708485993200_b4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122708485993200_b5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"2021122708485993200_b6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122708485993200_b7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"2021122708485993200_b8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00005","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"127","author":"Mechanic","year":"1997","journal-title":"Ann Intern Med"},{"key":"2021122708485993200_b9","first-page":"421","article-title":"Tumor necrosis factor production by human sarcoid alveolar macrophages","volume":"125","author":"Bachwich","year":"1986","journal-title":"Am J Pathol"},{"key":"2021122708485993200_b10","first-page":"569","article-title":"Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis","volume":"129","author":"Hunninghake","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2021122708485993200_b11","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4049\/jimmunol.137.11.3475","article-title":"Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis","volume":"137","author":"M\u00fcller-Quernheim","year":"1986","journal-title":"J Immunol"},{"key":"2021122708485993200_b12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2249.1997.d01-905.x","article-title":"Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters","volume":"107","author":"Takizawa","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2021122708485993200_b13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1172\/JCI111852","article-title":"Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis","volume":"75","author":"Robinson","year":"1985","journal-title":"J Clin Invest"},{"key":"2021122708485993200_b14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn's disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"key":"2021122708485993200_b15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/gut.52.11.1591","article-title":"Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis","volume":"52","author":"Ogura","year":"2003","journal-title":"Gut"},{"key":"2021122708485993200_b16","doi-asserted-by":"crossref","first-page":"36426","DOI":"10.1074\/jbc.M403861200","article-title":"Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae","volume":"279","author":"Opitz","year":"2004","journal-title":"J Biol Chem"},{"key":"2021122708485993200_b17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by Nod2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat Immunol"},{"key":"2021122708485993200_b18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"2021122708485993200_b19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/339432","article-title":"CARD15\/NOD2 mutational analysis and genotype\u2013phenotype correlation in 612 patients with inflammatory bowel disease","volume":"70","author":"Lesage","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2021122708485993200_b20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"2021122708485993200_b21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ajmg.10588","article-title":"Fine mapping of the IBD1 locus did not identify Crohn disease-associated","volume":"111","author":"Van Heel","year":"2002","journal-title":"Am J Med Genet"},{"key":"2021122708485993200_b22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/gast.2002.32413","article-title":"The molecular classification of the clinical manifestations of Crohn's disease","volume":"122","author":"Ahmad","year":"2002","journal-title":"Gastroenterology"},{"key":"2021122708485993200_b23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"key":"2021122708485993200_b24","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","article-title":"Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome","volume":"105","author":"Kanazawa","year":"2005","journal-title":"Blood"},{"key":"2021122708485993200_b25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/378076","article-title":"CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis","volume":"73","author":"Rahman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"2021122708485993200_b26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood-2003-10-3543","article-title":"Both donor and recipient NOD2\/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplntation","volume":"104","author":"Holler","year":"2004","journal-title":"Blood"},{"key":"2021122708485993200_b27","first-page":"20","article-title":"NOD2 and inflammatory disease","volume":"4","author":"Drewe","year":"2004","journal-title":"CPD Bull Immunol Allergy"},{"key":"2021122708485993200_b28","first-page":"15","article-title":"Inflammatory bowel disease: immunologic concepts","volume":"47","author":"Schreiber","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"2021122708485993200_b29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1572-0241.2007.01149.x","article-title":"Prevalence of CARD15\/NOD2 mutations in caucasian healthy people","volume":"102","author":"Hugot","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"2021122708485993200_b30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.micinf.2009.06.005","article-title":"Role of Nod2 in the development of Crohn's disease","volume":"11","author":"Yamamoto","year":"2009","journal-title":"Microbes Infect"},{"key":"2021122708485993200_b31","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/IAI.69.4.2277-2285.2001","article-title":"Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice","volume":"69","author":"Rath","year":"2001","journal-title":"Infect Immun"},{"key":"2021122708485993200_b32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.53.1.1","article-title":"Dysbiosis in inflammatory bowel disease","volume":"53","author":"Tamboli","year":"2004","journal-title":"Gut"},{"key":"2021122708485993200_b33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/649923","article-title":"Long term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo controlled trials","volume":"50","author":"Feller","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2021122708485993200_b34","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/gut.2003.032805","article-title":"NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression","volume":"53","author":"Wehkamp","year":"2004","journal-title":"Gut"},{"key":"2021122708485993200_b35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2007.08.013","article-title":"Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells","volume":"27","author":"Van Beelen","year":"2007","journal-title":"Immunity"},{"key":"2021122708485993200_b36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.immuni.2005.06.004","article-title":"NOD2 and Crohn's disease: loss or gain of function?","volume":"22","author":"Eckmann","year":"2005","journal-title":"Immunity"},{"key":"2021122708485993200_b37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni1092","article-title":"NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses","volume":"5","author":"Watanabe","year":"2004","journal-title":"Nat Immunol"},{"key":"2021122708485993200_b38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","article-title":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency","volume":"124","author":"Yu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708485993200_b39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.immuni.2007.12.012","article-title":"The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands","volume":"28","author":"Kim","year":"2008","journal-title":"Immunity"},{"key":"2021122708485993200_b40","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1073\/pnas.95.13.7502","article-title":"Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1","volume":"95","author":"Cho","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122708485993200_b41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng1096-199","article-title":"Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12","volume":"14","author":"Satsangi","year":"1996","journal-title":"Nat Genet"},{"key":"2021122708485993200_b42","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1086\/302913","article-title":"Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci","volume":"66","author":"Rioux","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2021122708485993200_b43","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1086\/302677","article-title":"Linkage of inflammatory bowel disease to human chromosome 6p","volume":"65","author":"Hampe","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2021122708485993200_b44","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1086\/302947","article-title":"High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12","volume":"66","author":"Duerr","year":"2000","journal-title":"Am J Hum Genet"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04216.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/3\/536\/41925136\/j.1365-2249.2010.04216.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/3\/536\/41925136\/j.1365-2249.2010.04216.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T22:48:55Z","timestamp":1685659735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/161\/3\/536\/6438669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,14]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,7,14]]},"published-print":{"date-parts":[[2010,8,16]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04216.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,9]]},"published":{"date-parts":[[2010,7,14]]}}}